LZ
Linping Zhang
President & CEO at Archimmune Therapeutics
Greater Boston
Overview
Linping Zhang is the President & CEO and Head of R&D at Archimmune Therapeutics, with a strong background in drug discovery, biotechnology, and pharmaceutical industry. Highlights of their career include serving as Senior Vice President at Fosun Pharma USA Inc. and Founding Scientist at Infinity Pharmaceuticals, Inc.
Linping Zhang's current role involves leading Archimmune Therapeutics and overseeing R&D efforts, with past experiences including key positions at Fosun Pharma USA Inc. and Infinity Pharmaceuticals, Inc.
Work Experience
President & CEO, Head of R&D
2023 - Current
Senior Vice President, Early Development
2022
Fosun Pharma USA is a pharmaceutical company that provides pharmaceutical injectable products and ophthalmic products.
Principal & co-founder
2018 - 2022
Venture Partner
2018 - 2020
Executive Director, Translational Sciences | Head of Clinical Development
2010 - 2018
Scientific Discovery Development
Associate Director, Project & Portfolio Management
2007 - 2010
Founding Scientist, Project Leader
2001 - 2006
Infinity Pharmaceuticals engages in the discovery and development of medicines for the treatment of cancer and related conditions.
Raised $538,040,191.00 from Biotechnology Value Fund and Purdue Pharma.
Postdoctoral Fellow
2000 - 2001
Sr. Principal Investigator
1990 - 1995